Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 255 - Carboxylic acid nitriles
Patents for C07C 255 - Carboxylic acid nitriles (27,066)
12/2005
12/21/2005CN1711238A Purification/decolorization treatment for fatty nitriles
12/21/2005CN1232504C Method for producing acrylonitrile, catalyst for use therein and method for preparing same
12/21/2005CN1232501C Preparing technology for cyclohexanol derivatives used to prepare the intermediate of Venlafaxine
12/20/2005US6977303 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
12/20/2005CA2171275C Stilbene derivatives and pharmaceutical compositions containing them
12/15/2005WO2005119794A1 Materials for photoelectric conversion devices and photoelectric conversion devices
12/15/2005WO2005119315A2 Non-linear optically active molecules, their synthesis, and use
12/15/2005WO2005118555A1 Dipeptidyl peptidase inhibitors
12/15/2005US20050277790 High-selective production method of di(aminomethyl)-substituted aromatic compound
12/15/2005US20050277784 Processes for the preparation of 2-cyano-3-naphthalene-1-yl-acrylic acid alkyl or benzyl esters
12/15/2005US20050277783 Processes for the preparation of 2-cyano-3-naphthalene-1-yl-3-phenyl-propionic acid alkyl or benzyl esters
12/15/2005US20050277680 tyrphostin-like compounds that display a significant potency as kinase inhibitors, cause the downregulation of c-myc proto-oncogene and inhibit the growth and survival of cancerous cell lines; antiproliferative agents
12/15/2005US20050277645 Sleep inducing compounds and methods relating thereto
12/15/2005US20050277547 Vapor phase oxidation of alkane or mixture of alkane and alkene to unsaturated carboxylic acid or ammoxidation to an unsaturated nitrile using a molybdenum or tungsten mixed oxide catalyst treated with nitric acid, ammonium nitrate, ammonium nitrite, nitrogen monoxide and/or nitrogen dioxide
12/15/2005CA2565705A1 Non-linear optically active molecules, their synthesis, and use
12/14/2005EP1604212A2 Modulators of the g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders
12/14/2005EP1603918A1 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof
12/14/2005EP1603865A1 Method for hydrocyanating an olefinically unsaturated compound
12/14/2005EP1603864A2 Diphenylethylene compounds and uses thereof
12/14/2005EP1603858A2 Kcnq channel modulating compounds and their pharmaceutical use
12/14/2005EP1603651A2 Distillative method for separating hexamethylenediamine from a mixture comprising hexamethylenediamine, -aminocapronitrile and tetrahydroazepine
12/14/2005EP1440052B1 Benzamide derivatives as antagonists of orexin receptors
12/14/2005EP1181268B8 Ammoxidation of a mixture of ketones to acetonitrile and hydrogen cyanide
12/14/2005EP1066258B1 Aryl phenyl substituted cyclic ketoenols
12/14/2005CN1708476A Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
12/14/2005CN1708475A Aromatic amine derivative and organic electroluminescent element employing the same
12/14/2005CN1231439C Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand
12/14/2005CN1231212C Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4
12/08/2005WO2005115994A1 Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates of the same, pesticides for agricultural and horticultural use, and usage thereof
12/08/2005WO2005115361A2 Androgen receptor modulators and method of treating disease using the same
12/08/2005US20050272941 The alkylation catalysts comprise a transition metal cation possessing multiple oxidation states that is embedded in a transition metal oxoanion possessing a higher oxidation state for the metal than the metal in the cation, such as copper chromite in the presence of rhodium
12/08/2005US20050272887 Fluorosulphonated nitrile crosslinkable elastomers based on vinylidene fluoride with low Tg and processes for preparing the same
12/08/2005US20050272765 Dipeptidyl peptidase inhibitors
12/08/2005US20050272036 Ketones
12/08/2005CA2566942A1 Androgen receptor modulators and method of treating disease using the same
12/07/2005EP1602405A1 Particulate porous ammoxidation catalyst
12/07/2005EP1601642A2 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
12/07/2005EP0912508B2 Process for preparing caprolactam from 6-aminocapronitrile
12/07/2005CN1704399A Fluorine-containing compound
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005US6972075 Distillation, separation of mixture
12/06/2005CA2163115C N-substituted beta-aryl- and beta-heteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation
12/01/2005WO2005113565A2 Metabolites of selective androgen receptor modulators and methods of use thereof
12/01/2005WO2005113506A1 Compounds and compositions as ppar modulators
12/01/2005WO2005113484A1 Phenyl carboxamide compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
12/01/2005US20050267306 Protected 3,5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and epothilone derivatives and process for the production
12/01/2005US20050267206 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
12/01/2005US20050267183 Selective estrogen receptor modulators
12/01/2005US20050267165 Il-8 receptor antagonists
12/01/2005US20050265686 Fluorine-containing compound
12/01/2005DE102004023522A1 Substituierte Cyclohexyl-1,4-diamin-Derivate Substituted cyclohexyl-1,4-diamine derivatives
12/01/2005CA2566053A1 Phenyl carboxamide compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
12/01/2005CA2564365A1 Compounds and compositions as ppar modulators
12/01/2005CA2563908A1 Metabolites of selective androgen receptor modulators and methods of use thereof
11/2005
11/30/2005EP1600471A1 Fluorine-containing compound
11/30/2005EP1599442A1 Process for preparing gamma-cyhalothrin
11/30/2005EP1599441A1 Process for the preparation of an alpha-amino carbonyl compound
11/30/2005EP1292569B1 Method for removing 6-aminocapronitrile from mixtures that contain 6-aminocapronitrile, adipodinitrile and hexamethylenediamine
11/30/2005EP0993463B1 Alkene borates and a process for covalently coupling organic compounds
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1703387A Preparation of at least one partial oxidation and/or ammoxidation product of propylene
11/30/2005CN1702094A Transparent resin material
11/30/2005CN1701814A F1K-1 is a receptor for vascular endothelial growth factor
11/30/2005CN1229338C Method for the production of unsaturated nitriles from alkanes
11/29/2005US6969728 Antiinflammatory agents
11/29/2005CA2306004C Process for preparing an aromatic compound substituted by a tertiary nitrile
11/24/2005WO2005111097A1 Adamantane derivative, method for producing same and photosensitive material for photoresist
11/24/2005WO2005110974A1 Substituted cyclohexyl-1,4-diamine derivatives
11/24/2005US20050261511 Catalytic oxidation process
11/24/2005US20050261499 Process for preparing (r)-aryloxypropionic acid ester derivatives
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005US20050258743 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof
11/23/2005EP1598067A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
11/23/2005EP1335898B1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
11/23/2005CN1701060A Ammoxidation of carboxylic acids to a mixture of nitriles
11/23/2005CN1701054A Method for the production of at least one partial propylene oxidation and/or ammoxidation product
11/23/2005CN1700923A Multi-substituted selective androgen receptor modulators and methods of use thereof
11/23/2005CN1228328C Pesticide intermediate compound
11/23/2005CN1228327C Carboxylic acid derivatives and drugs containing the same
11/23/2005CN1228315C Cyclopropanecarboxylic acid esters and pest controllers containing the same
11/22/2005CA2162122C Use of glycine-n,n-diacetic acid derivatives as biodegradable complexing agents for alkaline earth and heavy metal ions, and method of preparing them
11/17/2005WO2005108351A1 Benzonitrile derivatives to treat musculoskeletal frailty
11/17/2005WO2005108350A1 An improved and eco-friendly process for the preparation of 2-chlorenbenzylidene malononitrile (cs)
11/17/2005WO2005108348A1 Aromatic amine derivative, organic electroluminescent element employing the same, and process for producing aromatic amine derivative
11/17/2005WO2005108347A2 Substituted enaminones, their derivatives and uses thereof
11/17/2005WO2005108335A1 1,6-substituted 3,8-dihalogenopyrene and process for producing the same
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005US20050256340 Catalytically hydrogenating 4-(aminoalkoxy)benzonitrile in the presence of an organic solvent; preparing the aminoalkoxybenzonitriles from aminoalcohols and 4-halobenzonitrile
11/17/2005US20050256218 Containing a beta-diketone or a beta -ketoester; for example 3-{4-Acetyl-4-[2-(ethoxycarbonyl)ethyl]-5-oxohexanoyloxy}-2,2-dimethylpropyl ethyl 4,4-diacetylheptane-1,7-dioate; use in photocuring of UV curable ethylenically unsaturated compounds; yields colorless products; nonyellowing
11/17/2005US20050256201 Phenethanolamine derivatives
11/17/2005US20050256199 2-Amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
11/17/2005US20050256132 Use of ER selective NF-kB inhibitors for the treatment of sepsis
11/17/2005US20050255055 Protecting human and animal hair or skin from UV radiation by applying a 4,4-disubstituted -1,3-butadienylamine; 4,4-substituents may be the same or different and are cyano, ester, sec. or tert. amide, ketone and/or sulfone, e.g., 4,4-bis(hexyloxycarbonyl)-N,N-diethyl-1,3-butadienylamine
11/17/2005US20050254319 Polymer bound donor-acceptor-donor compounds and their use in a 3-dimensional optical memory
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/17/2005CA2565544A1 Benzonitrile derivatives to treat musculoskeletal frailty
11/16/2005EP1421634B1 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
11/16/2005EP1330464B1 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
11/16/2005CN1227232C Process for preparing non-steroid glucocorticoid receptor regulator
11/16/2005CN1227226C Preparation of Lactams from aliphatic alpha, omega-dinitriles
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 271